To establish the basis for the reduced expression of the X determinant on leukemic blasts and the changes i n antigenic expression that occur during myeloid maturation, the presence on myeloid cells of X and related structures was examined in conjunction with studies on the activities of the glycosyltransferases involved in their biosynthesis. Expression of X and sialyl-X was weak on blasts in comparison with neutrophils despite the presence of the requisite precursor structures. Much higher levels of 3-fucosyltransferase activity were found in blasts than in neutrophils when nonsialylated substrates were used. but, whereas the enzyme in neutrophils reacted equally well with 3'-sialylated and nonsialylated acceptors, the enzyme in blasts showed a marked preference for nonsialylated substrates. 6'-Sialyltransferase activity was strong in blasts but was not detectable in neutrophils, whereas a much lower level of 3'-sialyltrans- The carbohydrate structures recognized by monoclonal antibodies (MoAbs) are usually at the nonreducing ends of carbohydrate chains. Their synthesis is controlled by the activity of a series of glycosyltransferases, each one catalyzing the transfer of a single sugar in a specific linkage to a specific acceptor molecule. It is essential to understand the interactions between these enzymes if the mechanisms controlling the expression of cell surface carbohydrate antigens are to be fully understood. Although the most widely studied examples are the A and B blood grouprelated determinants, whose expression is controlled by the activity of specific blood group gene encoded glycosyltransferases,11.12 there has been much recent interest in the relationship between other cell surface carbohydrate struc- 0006-4971 /91/7806-0027$3..00/0 ferase activity was present in both blasts and neutrophils. Dimethyl sulfoxide-induced maturation of HL60 cells was associated with (1) a decrease in both 6'-sialyltransferase and 3-fucosyltransferase activities, (2) a change in the substrate specificity of 3-fucosyltransferase towards that found in mature cells, and (3) increased cell surface expression of sialyl-X. These results suggest that the reduced expression of X in myeloblasts is related t o the presence of the strong 6'-sialyltransferase, which uses the precursor substrate at the expense of the 3-fucosyltransferase and prevents the synthesis of X and sialyl-X. The developmental regulation of the levels of 3'-and 6'-sialyltransferases, and the level and specificity of the 3-fucosyltransferases, therefore controls the expression of X and its degree of sialylation.
To establish the basis for the reduced expression of the X determinant on leukemic blasts and the changes i n antigenic expression that occur during myeloid maturation, the presence on myeloid cells of X and related structures was examined in conjunction with studies on the activities of the glycosyltransferases involved in their biosynthesis. Expression of X and sialyl-X was weak on blasts in comparison with neutrophils despite the presence of the requisite precursor structures. Much higher levels of 3-fucosyltransferase activity were found in blasts than in neutrophils when nonsialylated substrates were used. but, whereas the enzyme in neutrophils reacted equally well with 3'-sialylated and nonsialylated acceptors, the enzyme in blasts showed a marked preference for nonsialylated substrates. 6'-Sialyltransferase activity was strong in blasts but was not detectable in neutrophils, whereas a much lower level of 3'-sialyltrans-
ELL DIFFERENTIATION and maturation in mam-
C malian cells involves an ordered program of changes involving cell to cell adhesion and recognition. Many of these interactions are mediated by cell surface carbohydrates on glycoproteins and glycolipid^,'.^ although their specific functions are generally not well understood. There are also striking differences between the cell surface carbohydrate structures found on normal and malignant ceIIs,5-' which have an important influence on the metastatic potential and other cell to cell interactions of tumour cells.&'o
The carbohydrate structures recognized by monoclonal antibodies (MoAbs) are usually at the nonreducing ends of carbohydrate chains. Their synthesis is controlled by the activity of a series of glycosyltransferases, each one catalyzing the transfer of a single sugar in a specific linkage to a specific acceptor molecule. It is essential to understand the interactions between these enzymes if the mechanisms controlling the expression of cell surface carbohydrate antigens are to be fully understood. Although the most widely studied examples are the A and B blood grouprelated determinants, whose expression is controlled by the activity of specific blood group gene encoded glycosyltransferases,11.12 there has been much recent interest in the relationship between other cell surface carbohydrate struc- The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with I8 U.S.C. section I734 solely to indicate this fact. ferase activity was present in both blasts and neutrophils. Dimethyl sulfoxide-induced maturation of HL60 cells was associated with (1) a decrease in both 6'-sialyltransferase and 3-fucosyltransferase activities, (2) a change in the substrate specificity of 3-fucosyltransferase towards that found in mature cells, and (3) increased cell surface expression of sialyl-X. These results suggest that the reduced expression of X in myeloblasts is related t o the presence of the strong 6'-sialyltransferase, which uses the precursor substrate at the expense of the 3-fucosyltransferase and prevents the synthesis of X and sialyl-X. The developmental regulation of the levels of 3'-and 6'-sialyltransferases, and the level and specificity of the 3-fucosyltransferases, therefore controls the expression of X and its degree of sialylation. 0 1991 b y The American Society of Hematology.
tures and their biosynthetic enzymes during cell differentiation and in different cell type^.'^.'^ On neutrophils, the most abundant surface carbohydrate structures on glycoproteins and glycolipids are based on type 2 polylactosamine chains, composed of repeating N-acetyllactosamine (NAL) (Galpl-4GlcNAc) sub~nits.'~-*~ The X determinant (Gal~l-4[Fucal-3]GlcNAc), which is the structure recognised by CD15 antibodies, is a fucosylated derivative of N-acetylla~tosamine.~~~~ The final stage in its synthesis is catalysed by a 3-fucosyltransferase (GDPfucose: N-acetyl-p-glucosaminide a1,3-fucosyltransferase) that transfers fucose to the 3-position of subterminal N-acetlylglucosamine residues at the ends of type 2 chains.% The determinant is expressed strongly on neutrophils and on all myeloid cells from the promyelocyte stage onward^.'^ However, expression on leukemic myeloblasts is frequently negative or weak,26x27 which is surprising in view of the high levels of activity of 3-fucosyltransferase in leukemic cells compared with mature neutrophils.28 Antigenic masking by sialic acid occurs to some extent because reactivity of acute myeloid leukemia (AML) cells with CD15 antibodies can be enhanced in some, but not all AML cells, by pretreatment with neuraminida~e.~~"
To explore the expression of the X determinant further and to determine whether it is possible to identify the activities of glycosyltransferases that influence this expression, we have studied the occurrence of X and its sialylated derivative, sialyl-Xi, and the activities of fucosyl-, 3'-sialyltransferase (CMP-N-acetylneuraminic acid: j3-Dgalactoside a2,3-~ialyltransferase) and 6'-sialyltransferase (CMP-N-acetylneuraminic acid: p-D-galactoside a2,6-sialyltransferase) in myeloid cells. We present our findings in normal neutrophils, leukemic myeloblasts, and HL60 cells induced to differentiate with dimethyl sulfoxide (DMSO).
MATERIALS AND METHODS

Cell Isolation
Neutrophils from seven normal volunteers were isolated from EDTA anticoagulated blood by density gradient centrifugation on
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Ficoll-Paque at 40% for 30 minutes.29 Erythrocytes contaminating the residual pellet were removed by hypotonic lysis in water restored to 0.15 mol/L saline after 30 seconds.
Leukemic blast cells from seven patients with AML were isolated from marrow taken into heparinised (20 U/mL) RPMI. Ceils were harvested from the mononuclear layer after centrifugation on Ficoll-Paque at 80% for 20 minutes. Leukemia was classified into French-American-British (FAB) subtypes on the basis of morphology and cytochemistry of marrow smears." All cells were washed twice in 0.15 mol/L NaCl containing 10 mmol/L Tris-HC1 pH 7.2 before final suspension in 0.15 mol/L NaCl (for glycosyltransferase assays) or phosphate-buffered saline (PBS) containing 2% fetal calf serum (FCS) and 0.1% azide (for marker studies). Cells were counted in a hemocytometer. Purity and morphology Of Cell SUSpeIISiOIIS was assessed from cytOCentI'ifUge preparations stained with May-Grunwald-Giemsa. In SOme experiments, cu-3-fucosyltransferase activity with nonsialylated and sialylated acceptors was compared. These assays Granulocytic differentiation was induced with DMSO. Cells were seeded at an initial concentration of 2.5 x 105/mL into duplicate flasks containing fresh medium with or without 1.3% DMSo. After periods Of growth between 30 minutes and 9 days, cells were harvested from the culture medium by centrifugation at differentiation." Viability was greater than 95% in all experiments, reduction was used to assess functional differentiation of induced cells?' Cancer Research7 London* uK). They do not differentiate in response to DMS033 and were cultured in identical conditions to HL60 ce11s as contro1s3 to exc1ude a direct effect Of DMSo On glycosyltransferase activity.
Enzyme Treatment
Indirect Immunofluorescence
LeuMl (CD15) was purchased from Becton Dickinson Immunocytometry Systems (Mountain View, CA). CSLEXl was kindly provided by Dr P. Terasaki (UCLA Tissue Typing Laboratory, Los Angeles, CA) as affinity-purified antibody at a concentration of 2.8 mg/mL. Antibodies 1B2 (hybridoma supernatant) and FH3 (ascitic fluid) were a gift of Prof S. Hakomori (Biomembrane Institute, Seattle, WA). Antibodies were used at maximal concentrations to just prevent neutrophil agglutination and thus allow direct comparison of staining intensity between blasts and neutrophils. Working dilutions were LeuMl 1:100, CSLEXl 1:100, 1B2 For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Radiolabeled glycoprotein remained at the origin and was separated from nucleotide sugar donor and free sugar.
Assays were performed with NAL or asialofetuin as acceptor molecules and contained the following: cell suspension 20 pL, 1% Triton-X100 5 pL, NAL 0.75 pmol or asialofetuin 400 pg, CMP-[14C]sialic acid 0.4 nmol, MnC1, 0.25 pmol, Na cacodylate, pH 6.4, 5.0 pmol (total volume 60 pL). Reaction mixtures were incubated for 4 hours at 37°C. With NAL, the radioactive products were separated from nucleotide donor and free sugar by high voltage paper electrophoresis (4,000 V, 90 minutes) on 3 MM paper in 40 mmol/L pyridine acetate buffer pH 5.4. The 3'-and 6'-sialyl-NAL reaction products obtained using NAL as acceptor have identical mobilities in the above system (Rplo 0.7) and, therefore, to distinguish 3'-and 6'4alyltransferase activities measured with this acceptor further, assays were performed in triplicate. The reaction products were pooled and the two isomers were further separated as follows. After electrophoresis the total product was identified by radiochromatogram scanning, eluted overnight with 100 mmol/L pyridine acetate buffer pH 5.4, evaporated, resuspended in H,O, and subjected to descending paper chromatography on Whatman No. 40 paper in ethyl acetate/ pyridineiacetic acid/H,O (5:5:1:3, by volume). 3'-and 6'-sialyl-NAL were identified by their mobilities relative to 3'-sialyllactose (1.4 and 1.0, respectively). In sialyltransferase assays with asialofetuin, the separation of products by chromatography was identical to that used for the 3-fucosyltransferase assay. Sialyltransferase activity.
P-4-Galactosyltransferase assays. p-4-Galactosyltransferase
RESULTS
Cell Marker Studies
The FAB subtypes of leukemic samples 1 through 4 were M4, M1, M2, and M1, respectively. Cytospin preparations of the mononuclear cell fractions isolated from marrow contained over 90% monomorphic blast cells in all but case 3, in which approximately 40% of the cells were more mature (promyelocytes and myelocytes).
The MoAbs used in this study recognize the X determinant and related oligosaccharide structures. Their specificities are shown in Table 1 .
LeuMl recognizes the X (CD15) determinant that is strongly expressed on mature neutrophils. The results in normal neutrophils and in three of the leukemic samples are illustrated in Fig la. The majority of cells from all four leukemic samples were negative with LeuMl at the antibody dilutions used in this study. In case 3, the positive fraction, when separated on the basis of light scattering," corresponded to the granulated population of promyelocytes and myelocytes identified on the cytospins. Similar results were obtained using the antibody FH3. CSLEXl. In a proportion of cases of AML, the expression of X is enhanced by prior treatment of the cells with neuraminidase, which suggests that antigenic masking by sialic acid may occur.26r27 We investigated this possibility using CSLEX1, an antibody that recognizes sialyl-X, the sialylated derivative of the X determinant. Neutrophils were strongly reactive with CSLEXl (Fig lb) and therefore express sialyl-X as well as X. The majority of cells from cases 1,2, and 4, by contrast, were only weakly reactive with the antibody. Again, in case 3 stronger reactivity appeared to be associated with cell maturity. Therefore, sialylation of 
LeuM1.
X determinant did not account for the reduced expression in myeloblasts compared with neutrophils. As an alternative means of assessing sialylation of X, the reactivity of cells with LeuMl was compared before and after neuraminidase treatment. The results obtained were consistent with those obtained with CSLEXl but this method was less sensitive.
To establish whether, despite high levels of the biosynthetic enzyme 3-fucosyltransferase in blasts, poor expression of X and sialyl-X might be explained by lack of a suitable precursor structure, we examined reactivity of the cells with 1B2, an antibody that recognizes the terminal disaccharide NAL that is the precursor of the X determinant. Expression of sialyl-NAL, the precursor of sialyl-X, was assessed by comparing reactivity with 1B2 before and after neuraminidase treatment of the cells. Untreated neutrophils were positive as shown in Fig lc, but reactivity was considerably enhanced by neuraminidase pretreatment (Fig Id) . On mature cells, therefore, that express both X and sialyl-X, the terminal NAL disaccharide structures exist in both sialylated and nonsialylated forms. In contrast, all four blast cell populations were negative initially but become strongly positive after neuraminidase treatment. This result suggests that, on leukemic cells, the NAL structures are present, but only as sialylated derivatives, sialyl-NAL.
Glycosyltransferase Activities 2-Fucosyltransferase. 2-Fucosyltransferase activity could not be demonstrated in neutrophils or in the blast cell preparations, as reported previo~sly.~~ 3-Fucosyliransferase. 3-Fucosyltransferase, which catalyzes the final step in the synthesis of the X determinant, transfers fucose to NAL structures (see Fig 2) at the ends of type 2 chains on glycoproteins and glycolipids. In confirmation of our previous observations,ZS activity of this enzyme was readily demonstrable in neutrophils but was present in much higher levels in leukemic blasts (Table 2) . Sialyltransferase. Sialyltransferase activity was present in neutrophils but was much higher in the leukemic cells (Table 2) , a finding consistent with strong expression of sialyl-NAL on blasts. Incorporation of ["C] sialic acid measured with asialofetuin was virtually identical to that with NAL (6.7 f 1.3 compared with 6.4 f 0.5 pmol sialic acid transferred/106 cells/h for blasts, mean f SD).
lB2.
A/-
To explore further the lack of expression of sialyl-X on myeloblasts despite apparently strong expression of sialyl-NAL and high levels of 3-fucosyltransferase and sialyltransferase, we distinguished 3'-and 6'4alyltransferase activities by separation of the reaction products (3'-and 6'4alyl-NAL) of the sialyltransferase activity with NAL as acceptor. The results in Table 3 show that the activity in neutrophils was exclusively due to 3'-sialyltransferase, whereas in the leukemic cells over 70% of the total activity was due to 6' 4alyltransferase.
Separation of 3'-and 6'-sialyltransferase products.
DMSO-Induced HL60 Cells
To determine the extent to which the differences between leukemic myeloblasts and normal mature cells might reflect the changes occurring during normal myeloid maturation, we studied HL60 cells induced to differentiate with DMSO. Morphologic evidence of maturation was present in 80% to 90% of treated cells and by 6 or 7 days most had progressed to myelocyte and metamyelocyte stages. Phorbo1 myristate acetate (PIMA)-stimulated superoxide production (measured by cytochrome c reduction) increased from 0 to 18 nmol/107 cells/h by day 5. The morphologic changes were accompanied by alterations in both antigen expression and enzyme activity. 41 However, the expression of sialyl-X increased until by day 5 a population (20% to 30%) of the cells was strongly positive
In uninduced cells elevated levels of 3-fucosyl-and sialyltransferase were present, comparable with those in leukemic blasts. After 24 hours of exposure to DMSO, a reduction in the level of both enzymes was apparent, (as illustrated in Fig 4) by which time the levels had decreased to 60% and 40%, respectively, of those measured in uninduced cells. A predominance of 6'-sialyltransferase was measured in uninduced cells similar to that found in leukemic blasts and the decrease in total sialyltransferase activity that accompanied DMSO-induced maturation was due to loss activity of this enzyme (Fig 5) . 3'-Sialyltransferase remained unchanged at 24 hours and decreased only slightly by day 6.
The DMSO-related changes in enzyme activities were not due to an alteration in the rate of cell growth; this continued at an exponential rate for 48 hours after exposure to DMSO. To exclude a direct effect of DMSO on glycosyltransferase activities, we measured the activity of 0 (Fig 3) . P-4-galactosyltransferase in HL60 cells that remained unchanged during the period of exposure (data not shown). 3-Fucosyl-and total sialyltransferase activities in KG1 cells exposed to DMSO for 48 hours remained at 89% and 100% of control values, respectively.
2-
3-Fucosyltransferase Activity Measured with Sialylated and Nonsialylated Acceptors
3-Fucosyltransferase activity in blasts and HL60 cells was approximately 10-fold greater than in neutrophils when measured with asialofetuin, as was found also with NAL as acceptor. However, activity in the mature cells was similar when measured with fetuin or asialofetuin, with a slight preference for asialofetuin (see Fig 6) , whereas in AML blasts and HL60 cells there was a marked difference. and sialylated low molecular weight acceptors (NAL and 3'-sialyl-NAL) showed a similar pattern (see Table 4 ), with the blasts again showing 5 times greater preference than the mature cells for NAL, as compared with 3'4alyl-NAL. When HL60 cells were induced with DMSO, a marked decrease in total 3-fucosyltransferase activity measured with asialofetuin occurred (as with NAL as acceptor), but, in addition, a change in enzyme specificity was apparent in the direction of a less marked preference for asialofetuin as cell maturation progressed (Fig 6) . In blasts, in contrast to the findings with sialyltransferase, a direct comparison between incorporation of ["C] fucose measured with NAL and asialofetuin showed that it was more than 100-fold greater with NAL (549 & 391 compared with 1.1 f 0.6 pmol fucose transferred/106 cells/h), which suggests that asialofetuin is a rather poor acceptor for this enzyme.
DlSCUSSlON
These results show that (1) expression of X and sialyl-X on leukemic myeloblasts is markedly reduced compared with neutrophils and (2) the activity of the biosynthetic 3-fucosyltransferase and sialyltransferases is different in these two cell types. We suggest that the differences between surface carbohydrate expression in immature and mature cells can be accounted for by their different enzyme profiles.
The virtual absence of reactivity of blasts with LeuMl described here is not strictly comparable with results of other because we deliberately used nonsaturating concentrations of antibody and, in all but case 2, weak reactivity could be induced by increasing the antibody concentration to a level at which marked agglutination of neutrophils occurred. Lack of reactivity was not due to antigenic masking of X by sialic acid, to any major extent, because the expression of sialyl-X was also weak. The enzymic studies suggest that lack of X expression is most probably related to high levels of 6'-sialyltransferase, which uses the precursor substrate, thereby preventing the synthesis of either X or sialyl-X as shown in Fig 2. In blasts, 3-fucosyltransferase and 6'-sialyltransferase would be expected to be the major competitors for NAL substrate. How much X or 6'-sialyl-NAL is formed is therefore likely to be determined by the relative activities of the two enzymes. A strongly active 6'-sialyltransferase would use NAL end groups to form 6'-sialyl-NAL structures, at the expense of 3-fucosyltransferase. In neutrophils, 6'-sialyltransferase activity is absent, leaving 3-fucosyltransferase and 3'-sialyltransferase as the major competitors for NAL. The synthesis of X and sialyl-X will therefore depend on the relative activities of these two enzymes. Initial fucosylation of NAL by 3-fucosyltransferase would result in X but not sialyl-X, whose synthesis proceeds via sialylation, followed by fucosylation as in Fig 2. '' Initial sialylation of NAL by 3'-sialyltransferase would result in 3'-sialyl-NAL, which can then be converted to sialyl-X. The marker studies in neutrophils are in agreement with this pattern of activity and show surface NAL, sialyl-NAL, X and sialyl-X structures. The appearance of unsubstituted NAL end groups is likely to be a result of lower overall activities of both enzymes.
The apparent predominance of 6'-sialyltransferase activity in blasts and lack of effective competition for NAL by 3-fucosyltransferase is surprising in view of the markedly elevated level of 3-fucosyltransferase activity compared with sialyltransferase activity. There was no evidence for the presence of fucosidases on prolonged incubations of reaction mixtures, or for inhibitors. Limited availability of GDP-fucose or divalent cations might be important controlling influences; 3-fucosyltransferase in neutrophils has an absolute requirement for Mn", whereas 3'-and 6'-sialyltransferase do not (unpublished observations). However, the higher comparative levels of 3-fucosyltransferase were evident only when the low molecular weight compound NAL was used as acceptor; with asialofetuin as acceptor molecule, 3-fucosyltransferase activity was actually considerably less than that of 6'-sialyltransferase (1.1 & 0.6 compared with 6.7 2 1.3 pmol sugar transferred/ 106 cells/h). It is probable, therefore, that 3-fucosyltransferase demonstrates fine substrate specificity such that the complexity of the oligosaccharide structures internal to NAL or the surface conformation of glycoprotein and glycolipid molecules influence its activity in a major way. The length and complexity of oligosaccharide moieties isolated from blasts and neutrophils are very different,42 and analysis of neutrophil glycoproteins suggests that glycosyltransferases acting on NAL structures at the ends of tetra-antennary N-linked chains do exhibit branch specificFor personal use only. on October 3, 2017. by guest www.bloodjournal.org From ity." Gangliosides with terminal 2-6 sialyl type 2 chains and internal fucose residues have been shown to be much higher in malignant than in normal t i~s u e s~~~" and it is possible that 2-6 sialyl type 2 chains on leukemic myeloblasts could also be internally fucosylated. However, such fucose would not give rise to X or sialyl-X structures and would not have been detected in this study. Although the X determinant can be demonstrated on both glycoprotein and glycolipid isolated from HL60 it is not known whether on blasts it occurs preferentially on one or the other. Glycolipid acceptors were not used in this study but clearly the use of different and more complex acceptors, together with detailed examination of the exact distribution of X during early stages of cell maturation, will be necessary to fully appreciate these complex interdependent mechanisms.
The expression of X during normal myeloid maturation does appear to be developmentally regulated. It first appears at or just before the promyelocyte stage".46 but is absent in earlier precursors. Lack of expression on leukemic blasts due to high levels of 6'4alyltransferase may, therefore, simply be a feature of immaturity rather than leukemic transformation with the occurrence of X and/or sialyl-X influenced in a major way by the interaction between 6'-sialyltransferase, 3'-sialyltransferase, and 3-fucosyltransferase which, in turn, will be determined by the precise stage of maturation arrest of the leukemic cells.
The strong expression of X on HL60 cells, which also have high levels of 3-fucosyltransferase and 6'-sialyltransferase, suggests that, in these cells, both enzymes compete effectively for substrate. The changes in enzyme activity after exposure to DMSO also suggest a developmentally regulated reduction in 3-fucosyl-and 6'-sialyltransferase activities. These changes were accompanied by a population of cells with increased expression of sialyl-X, presumably because the decrease in both enzyme levels encouraged more effective competition for NAL by 3'-sialyltransferase.
The reduced activity with sialylated substrates demonstrated by the 3-fucosyltransferase in blasts is also likely to have an important regulatory influence on the expression of sialyl-X. The marker studies did not distinguish between surface 3'-and 6'4alyl-NAL structures, but even if a significant proportion of the sialyl linkages were a-2,3 it is probable that these structures could not have been converted to sialyl-X by the 3-fucosyltransferase present at this stage of maturation. Whether the observed differences in substrate specificity of the 3-fucosyltransferase during cell maturation are due to changes in a single enzyme or whether two distinct enzymes are expressed independently is not clear. However, Johnson and Watkin~~'.~' reported similar differences in purified 3-fucosyltransferases from CGL cells and normal neutrophils, and both enzymes appeared to be distinct from the 3-fucosyltransferase isolated from plasma. Two 3-fucosyltransferases are also present in mutant CHO cells lines and show different specificities for sialylated Interestingly, the introduction of a 3-fucosyltransferase cDNA from HL60 cells into wild type CHO cells by transfection resulted in demonstrable 3-fucosyltransferase activity that was distinct from the two described in mutant cells but resembled the HL60 enzyme described here?'
The biologic role of sialyl-X is unknown. However, it is tempting to speculate that it may be important in cellular adhesion mechanisms, particularly those that determine the release of mature neutrophils from the bone marrow into the circulation. X and sialyl-X structures are abundant on most, if not all, N-linked glycoproteins isolated from mature neutrophil^,'^^'^ and the integrin glycoproteins, LFAl Macl, and p150,95, which are important mediators of cell adherence, have predominantly N-linked oligosaccharides. They are rich in X structures and it is highly probable that they also express sialyl-X. It has been suggested that increased sialylation of cell surface oligosaccharides in CGL is responsible for the premature release of cells into the circulation and other in vitro abnormalities of adherence: The precise nature of this aberrant sialylation is not known, but whether it involves increased expression of sialyl-X and how this relates to altered glycosyltransferase activity is worthy of further study. Elevated activity of an a2,3-sialyltransferase that acts on Galpl3GalNAc residues in 0-linked oligosaccharides has recently been demonstrated in CGL cells:' but to what extent this is responsible for increased sialylation of functional importance is not clear because in neutrophils only one glycoprotein, leukosialin, has been found to contain predominantly 0-linked structures.4' The development of molecular techniques such as transfection of cloned glycosyltransferases to alter terminal glycosylation sequence^^^^^' will greatly improve our understanding of the biologic importance of cell surface carbohydrate structures and the factors regulating their synthetic control in malignant transformation and during normal differentiation.
